BNP Paribas Completes Exane Acquisition
BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership.
This milestone represents a new chapter for both BNP Paribas and Exane, thanks to the strong collaboration and long-standing commitments from the teams of both firms.
We’ve completed the acquisition of 100% of Exane!
With Exane’s expertise in #cashequities & #derivatives, @BNPParibas can offer institutional investors & corporates a full suite of services & solutions on equities 👉 https://t.co/exXfHWnR2Q pic.twitter.com/NJXnmvmro5
— BNP Paribas CIB (@BNPParibasCIB) July 13, 2021
Leveraging Exane’s expertise in cash equities (execution and research) and derivatives, BNP Paribas will be able to provide a full suite of services on equities to Institutional investors and Corporates worldwide, positioning the bank as a leading provider in Global Equities.
Source: BNP Paribas
Morgan Stanley CEO wants the Fed to raise rates in March.
A fall in overall risk appetite and exiting prime services contributed to the loss.
Firm is investing up to $150m to anchor the team's first strategy.
Management set key performance indicators to track progress of its strategic plan from 2020.
The bank failed to protect customers’ securities and disclosed conflicts of interest inaccurately.